Malte Leithäuser

1.4k total citations
21 papers, 484 citations indexed

About

Malte Leithäuser is a scholar working on Pathology and Forensic Medicine, Oncology and Hematology. According to data from OpenAlex, Malte Leithäuser has authored 21 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 7 papers in Oncology and 6 papers in Hematology. Recurrent topics in Malte Leithäuser's work include Lymphoma Diagnosis and Treatment (7 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Malte Leithäuser is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Malte Leithäuser collaborates with scholars based in Germany, United States and Switzerland. Malte Leithäuser's co-authors include Véronique Leblond, Franck Morschhauser, Martine Raphaël, Heinz A. Horst, Ioannis Anagnostopoulos, Petra Reinke, Arnaud Jaccard, Stephan Oertel, Monica Sender and Peter Mollee and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.

In The Last Decade

Malte Leithäuser

20 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malte Leithäuser Germany 9 280 219 89 86 79 21 484
Cannon Milani United States 7 324 1.2× 282 1.3× 39 0.4× 89 1.0× 25 0.3× 11 455
Michael Jaglal United States 12 148 0.5× 84 0.4× 54 0.6× 96 1.1× 24 0.3× 78 420
Roberta Della Pepa Italy 12 110 0.4× 109 0.5× 39 0.4× 30 0.3× 51 0.6× 35 367
Éric Hermet France 12 214 0.8× 92 0.4× 23 0.3× 84 1.0× 81 1.0× 31 548
Adonis Lorenzana Canada 12 113 0.4× 65 0.3× 71 0.8× 43 0.5× 27 0.3× 27 404
Chiara Savignano Italy 11 159 0.6× 88 0.4× 42 0.5× 73 0.8× 59 0.7× 27 381
Ka‐Wah Chan United States 9 164 0.6× 48 0.2× 53 0.6× 36 0.4× 63 0.8× 15 459
Stanley Lowenbraun United States 13 295 1.1× 161 0.7× 52 0.6× 62 0.7× 188 2.4× 18 505
Haytham Dimashkieh United States 11 158 0.6× 71 0.3× 53 0.6× 15 0.2× 77 1.0× 16 454
Carlo Moroni Italy 8 135 0.5× 145 0.7× 14 0.2× 114 1.3× 92 1.2× 17 340

Countries citing papers authored by Malte Leithäuser

Since Specialization
Citations

This map shows the geographic impact of Malte Leithäuser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malte Leithäuser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malte Leithäuser more than expected).

Fields of papers citing papers by Malte Leithäuser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malte Leithäuser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malte Leithäuser. The network helps show where Malte Leithäuser may publish in the future.

Co-authorship network of co-authors of Malte Leithäuser

This figure shows the co-authorship network connecting the top 25 collaborators of Malte Leithäuser. A scholar is included among the top collaborators of Malte Leithäuser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malte Leithäuser. Malte Leithäuser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmoll, Hans‐Joachim, Benjamin Garlipp, Christian Junghanß, et al.. (2017). FOLFOX/Bevacizumab +/− Irinotecan in advanced colorectal cancer (AIO) “CHARTA”: Final results and multivariate prognostic factor analysis. Annals of Oncology. 28. iii152–iii152. 1 indexed citations
2.
Schmoll, Hans‐Joachim, Benjamin Garlipp, Christian Junghanß, et al.. (2017). “CHARTA”: FOLFOX/Bevacizumab vs. FOLFOXIRI/Bevacizumab in advanced colorectal cancer—Final results, prognostic and potentially predictive factors from the randomized Phase II trial of the AIO.. Journal of Clinical Oncology. 35(15_suppl). 3533–3533. 15 indexed citations
3.
Schmoll, Hans‐Joachim, Benjamin Garlipp, Christian Junghanß, et al.. (2016). FOLFOX / Bevacizumab (Beva) +/- Irinotecan in advanced colorectal cancer (CRC): A randomized phase II trial (AIO KRK 0209, CHARTA). Annals of Oncology. 27. vi560–vi560. 1 indexed citations
4.
Korfel, Agnieszka, Michael Weller, Peter Martus, et al.. (2012). Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial. Annals of Oncology. 23(9). 2374–2380. 39 indexed citations
5.
6.
Jahnke, Kristoph, Agnieszka Korfel, Peter Martus, et al.. (2011). Prognostic factors for response and survival in primary central nervous system lymphoma (PCNSL) from a randomized phase III trial (G-PCNSL-SG-1).. Journal of Clinical Oncology. 29(15_suppl). 2004–2004. 2 indexed citations
7.
Lampe, Hans, Malte Leithäuser, Christian Junghanß, & M. Freund. (2011). Treating Colorectal Cancer with Western and Chinese Medicine. 2(4). 341–350. 1 indexed citations
8.
Korfel, Agnieszka, L. Fischer, Peter Martus, et al.. (2011). Impact of meningeal dissemination (MD) on outcome in primary CNS lymphoma in the G-PCNSL-SG1 trial. Journal of Clinical Oncology. 29(15_suppl). 2026–2026. 1 indexed citations
9.
Kahl, Christoph, et al.. (2011). Rezidivierende Hypoglykämien und ein großer intraabdominaler Tumor bei einer 61-jährigen Patientin. DMW - Deutsche Medizinische Wochenschrift. 136(49). 2542–2546.
10.
Trappe, Ralf Ulrich, Stephan Oertel, Véronique Leblond, et al.. (2011). Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. The Lancet Oncology. 13(2). 196–206. 252 indexed citations
11.
Kahl, Christoph, Carsten Hirt, Susanne Decker, et al.. (2010). Multimodal Therapy for Localized Spinal Epidural Follicular Lymphoma. Onkologie. 33(7). 4–4. 7 indexed citations
12.
Leithäuser, Malte, Christoph Kahl, Christian Aepinus, et al.. (2009). Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation. Transplant Infectious Disease. 12(3). 251–257. 15 indexed citations
13.
14.
15.
Wolf, Hans‐Heinrich, Malte Leithäuser, Georg Maschmeyer, et al.. (2008). Central venous catheter-related infections in hematology and oncology. Annals of Hematology. 87(11). 863–876. 53 indexed citations
16.
Schultz, Anders Nikolai Ørsted, et al.. (2007). Urogenitale Lymphommanifestationen. Aktuelle Urologie. 38(4). 324–327. 1 indexed citations
17.
Junghanß, Christian, Michaela Waak, A. Knopp, et al.. (2005). Multivariate analyses of prognostic factors in acute myeloid leukemia: relevance of cytogenetic abnormalities and CD34 expression.. PubMed. 52(5). 402–10. 13 indexed citations
18.
Wolff, Daniel, Beate Steiner, S. Stilgenbauer, et al.. (2004). Treatment with campath‐1H for relapsed chronic lymphocytic leukemia after allogeneic peripheral blood stem cell transplantation does not abrogate the development of chronic GVHD. European Journal Of Haematology. 72(2). 145–148. 5 indexed citations
19.
Wolff, Daniel, Frank Reichenberger, Beate Steiner, et al.. (2002). Progressive interstitial fibrosis of the lung in sclerodermoid chronic graft-versus-host disease. Bone Marrow Transplantation. 29(4). 357–360. 27 indexed citations
20.
Junghanß, Christian, Malte Leithäuser, Stefan Wilhelm, et al.. (2001). High-dose etoposide phosphate and G-CSF mobilizes peripheral blood stem cells in patients that previously failed to mobilize. Annals of Hematology. 80(2). 96–102. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cannon Milani Breakdown of academic impact, for papers by Michael Jaglal Breakdown of academic impact, for papers by Roberta Della Pepa Breakdown of academic impact, for papers by Éric Hermet Breakdown of academic impact, for papers by Adonis Lorenzana Breakdown of academic impact, for papers by Chiara Savignano Breakdown of academic impact, for papers by Ka‐Wah Chan Breakdown of academic impact, for papers by Stanley Lowenbraun Breakdown of academic impact, for papers by Haytham Dimashkieh Breakdown of academic impact, for papers by Carlo Moroni
Rankless by CCL
2026